1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInnovative Health Initiative (IHI) is sponsored by Innovative Health Initiative (IHI) - a public-private partnership with the European Union. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Innovative Health Initiative (IHI) - MedTech Europe Innovative Health Initiative (IHI) The Innovative Health Initiative (IHI) is a public-private partnership between the European Union and the European life science industries, under the EU R&I funding programme Horizon Europe. IHI was launched in 2021 and will run until 2027.
This cross-sectoral partnership unites all key stakeholders in healthcare, including five major industry sectors (COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe), alongside public partners and patients. Its mission is to drive significant progress in addressing unmet health needs across Europe.
By leveraging expertise from medical technologies, pharmaceuticals, biotechnology and big data, IHI funds collaborative projects that aim to deliver tangible health outcomes, improve patients’ lives, and boost the global competitiveness of Europe’s health industries.
Pioneer the patient-centred integration of knowledge, technology, and products Tackle every aspect of care to improve the lives of patients across Europe and beyond Strengthen Europe’s position at the forefront of medical innovation Address current and future health challenges What is in it for you as a medical technology company? The IHI programme is an exciting opportunity for medical technology companies.
By participating , you can shape your company’s future research, collaborate with public and private partners across sectors to improve healthcare, build innovative solutions, find out where your expertise can make a difference, and address health challenges with a broader diversity of approaches.
Navigating the IHI journey: support from MedTech Europe MedTech Europe is proud to be among five industry associations that have come together, representing pharmaceutical, biotech and medical technologies industries operating in Europe (COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe). The Research & Innovation Team of MedTech Europe is here to help its members navigate from A to Z along their journey towards IHI .
For further information on templates, guidelines, and other resources, please contact Jeroen Schuermans , Director Strategic Initiatives We can provide you with the following: Tailored deep dive webinars On-site or remote meetings with your teams Valuable resources and educational materials Support and guidance at any time IHI funding model: investing in innovation The IHI is funded jointly by the European Union (represented by the European Commission) and the life science industries (represented by COCIR, EFPIA, Vaccines Europe, EuropaBio , and MedTech Europe).
The total budget for IHI for the period 2021-2027 is € 2. 4 billion .
Half of this budget comes from cash contributions from Horizon Europe, the other half from contributions from the industry ( € 1 billion from, mostly, in-kind from the IHI industry partners and €200 million from other life science industries or associations that contribute to IHI as contributing partners ) Podcast - The Innovative Health Initiative (IHI): the future of Research and Innovation in healthcare in Europe Patrick Boisseau, previous Director General Industry Strategic Initiatives at MedTech Europe, explains what is the Innovative Health Initiative, which aims at delivering integrated and impactful patient-centric solutions thanks to cross-sectorial public-private partnerships.
MedTech ON AIR · The Innovative Health Initiative: the future of Research and Innovation in healthcare in Europe Contributing in-kind to an Innovative Health Initiative (IHI) project Director Strategic Initiatives ai5zY2h1ZXJtYW5zQG1lZHRlY2hldXJvcGUub3Jn Director Strategic Initiatives ai5zY2h1ZXJtYW5zQG1lZHRlY2hldXJvcGUub3Jn Jeroen joined MedTech Europe in July 2025 as Director Strategic Initiatives.
He leads the organisation’s work on EU health research and public funding, with a strong focus on the Innovative Health Initiative (IHI). His role includes shaping and promoting the MedTech industry’s position in EU Research and Innovation Partnerships and supporting strategic engagement with European institutions and stakeholders. Jeroen brings over a decade of experience in EU-funded health research programmes.
He has supported companies and academic stakeholders in securing and managing large-scale collaborative projects under H2020, Horizon Europe, IMI/IHI, and other Joint Undertakings. Prior to joining MedTech Europe, Jeroen was Senior Manager Funding & Strategic Partnerships, where he led multidisciplinary teams and worked closely with companies and research institutions on project development (pre-award) and execution (post-award).
Jeroen was educated a Biochemist (KU Leuven) and molecular neuroscientist at VIB-KU Leuven Center for Brain & Disease Research. A Belgian national and native Dutch speaker, Jeroen is also fluent in English. In his free time, Jeroen enjoys hiking with his dog and exploring nature.
Innovative Health Initiative (IHI) – The flagship partnership for healthcare research & innovation in Europe Key IHI support and upcoming opportunities Innovative Health Initiative (IHI) – The flagship partnership for healthcare research & innovation in Europe Driving innovation in health: Innovative Health Initiative (IHI) call 12 now open Innovative Health Initiative (IHI) – The flagship partnership for healthcare research & innovation in Europe Innovative Health Initiative (IHI) events – Regulatory impact online session and IHI call 12 Info Days MedTech Europe's position on the MDR/IVDR revision The MDR/IVDR revision marks a pivotal moment for the EU medtech sector.
Read MedTech Europe's full position on the revision.
According to the current listing, eligibility includes: All key stakeholders in healthcare, including five major industry sectors (COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe), alongside public partners and patients. Confirm the full requirements in the official notice before applying.
Innovative Health Initiative (IHI) is funded by Innovative Health Initiative (IHI) - a public-private partnership with the European Union. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NSF 26-501 (CAMEL) commits $9 million to build AI-ready K-12 mathematics datasets across 6–7 awards of up to $1.5 million each. The money is co-supported by the Walton Family Foundation — and the solicitation bars WFF staff and partners from participating in any capacity, prohibits voluntary cost sharing, and requires reports be shared with the foundation after NSF review. Here's how the public-private structure works, and what Phase II means for teams already in.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleHRSA-26-078 splits $9.1 million among roughly 10 Public Health Training Centers, with awards up to $910,000 and applications due July 17, 2026. Eligibility runs to accredited schools of public health and other nonprofit training institutions. Here's why the winning applications are the ones that can prove an existing, mapped relationship with state and local health departments — not the ones promising the slickest coursework.
Read article